FDA Inspection 640977 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3003733819

The FDA completed an inspection of Biomat USA, Inc. on January 27, 2010 in Indianapolis, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 27, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Indianapolis, IN (United States)